The government is scrambling to reorient its Covid-19 vaccination plans after new evidence emerged on Sunday that AstraZeneca’s vaccine does not protect people against mild to moderate disease caused by the new variant detected in SA late last year. This vaccine is the cornerstone of the first phase of SA’s Covid-19 immunisation strategy.

"It is a temporary issue, until we figure out the next steps," health minister Zweli Mkhize said in a late night briefing. "The plan is to find out from scientists how to use it going forward."..

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.